All five markers of obesity-related inflammation in the hippocampus (Il-6, Tnf-α, Cd11c, Tlr4 and Nptx251,52) were down-regulated by ENOblock treatment (Fig. 6A). Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.